Literature DB >> 10784311

Trimethoprim-sulfamethoxazole-induced aseptic meningitis: case report and literature review.

C Capra1, G M Monza, G Meazza, G Ramella.   

Abstract

Aseptic meningitis is a rare adverse drug reaction, reported with non-steroidal anti-inflammatory agents (NSAIDs) and with miscellaneous drugs such as trimethoprim-sulfamethoxazole (TMP-SMX). The most common clinical findings reported are fever, headache, stiffness and altered level of consciousness. We report a case of aseptic meningitis related to TMP-SMX ingestion that caused severe derangements of the patient's vital signs, requiring Intensive Care Unit admittance. The prompt diagnosis and discontinuation of the drug resulted in complete recovery. We examine the case according to the literature on this topic. We conclude that, since the signs and symptoms of this unusual drug reaction may mimic those of central nervous system infection, the clinician should consider this etiology when he is faced with a patient with suspected meningoencephalitis, especially if the latter has already been treated at home with unknown drugs. Further studies should investigate the pathogenetic mechanism of TMP-SMX-induced aseptic meningitis.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10784311     DOI: 10.1007/s001340050048

Source DB:  PubMed          Journal:  Intensive Care Med        ISSN: 0342-4642            Impact factor:   17.440


  5 in total

Review 1.  [Procalcitonin-based algorithm. Management of antibiotic therapy in critically ill patients].

Authors:  M Hochreiter; S Schroeder
Journal:  Anaesthesist       Date:  2011-07       Impact factor: 1.041

2.  Severe dapsone hypersensitivity syndrome in a child.

Authors:  So Yoon Choi; Ho Yeon Hwang; Jung Hyun Lee; Jae Sun Park; Min Soo Jang
Journal:  Korean J Pediatr       Date:  2013-06-21

3.  Cost-effectiveness analysis of diagnostic options for pneumocystis pneumonia (PCP).

Authors:  Julie R Harris; Barbara J Marston; Nalinee Sangrujee; Desiree DuPlessis; Benjamin Park
Journal:  PLoS One       Date:  2011-08-15       Impact factor: 3.240

Review 4.  Cotrimoxazole - optimal dosing in the critically ill.

Authors:  Glen R Brown
Journal:  Ann Intensive Care       Date:  2014-04-28       Impact factor: 6.925

5.  Cerebrospinal Fluid Characterization in Cynomolgus Monkeys, Beagle Dogs, and Göttingen Minipigs.

Authors:  Cristina Ballesteros; Mylène Pouliot; Rémi Froment; Mohamed Said Maghezzi; Camille St-Jean; Christian Li; Dominique Paquette; Simon Authier
Journal:  Int J Toxicol       Date:  2020-02-18       Impact factor: 2.032

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.